Yasho Industries Q3 FY26: ₹201 Cr Revenue, 35% YoY Surge but 101 PE & 1.37 Debt/Equity – Specialty Chemical Star or Overleveraged Experiment?
1. At a Glance – The Chemical Cocktail Is Bubbling, But Is It Boiling?
Yasho Industries Ltd is currently trading at ₹1,506, with a market cap of ₹1,815 crore. The stock has fallen 11.6% in the last 3 months and 21.3% in one year. Meanwhile, Q3 FY26 numbers show revenue of ₹201.83 crore (+35% YoY) and PAT of ₹4.50 crore — a 649% jump over last year’s low base. Sounds heroic, right?
But hold your beaker.
The stock trades at a P/E of 101, price-to-book of 4.26, ROCE of just 7.23%, and ROE of 1.63%. Debt stands at ₹584 crore, giving a debt-to-equity ratio of 1.37. Interest coverage? A nervous 1.44.
So here’s the spicy paradox:
Revenue is growing. Margins are stabilizing. But returns are weak. And valuation is… enthusiastic.
Is this a temporary margin squeeze story before the Pakhajan plant scales up? Or is this a classic “growth without returns” specialty chemical saga?
Let’s dive deep.
2. Introduction – The Jhaveri Chemical Empire
Founded in 1985 by Mr. Vinod Jhaveri, Yasho Industries operates in the glamorous world of specialty chemicals. Not your everyday shampoo-and-soap chemicals. This is the behind-the-scenes chemistry that makes tires durable, perfumes fragrant, and edible oils stable.
They manufacture 148 products across five verticals:
Food Antioxidants
Aroma Chemicals
Rubber Chemicals
Lubricant Additives
Specialty Chemicals
Exports contribute roughly 65% of revenue, serving 50+ countries.
But here’s the twist.
They built a shiny new greenfield plant at Pakhajan, added R&D muscle (40+ chemists), expanded capacity… and then margins slipped, debt shot up, and interest cost ballooned.
Classic specialty chemical expansion cycle.
When capacity ramps up faster than demand, balance sheets feel the pressure.
Question for you: Is Yasho in the “pain before gain” phase? Or just stuck in expansion
